353 related articles for article (PubMed ID: 25547425)
1. Microcytic anemia in a pregnant woman: beyond iron deficiency.
Rollón N; Fernández-Jiménez MC; Moreno-Carralero MI; Murga-Fernández MJ; Morán-Jiménez MJ
Int J Hematol; 2015 May; 101(5):514-9. PubMed ID: 25547425
[TBL] [Abstract][Full Text] [Related]
2. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
3. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
[TBL] [Abstract][Full Text] [Related]
4. [Successful treatment of X-linked sideroblastic anemia with ALAS2 R452H mutation using vitamin B
Kawakami T; Nakazawa H; Kawakami F; Matsuzawa S; Sudo Y; Sakai H; Nishina S; Senoo N; Senoo Y; Komatsu M; Umemura T; Yamaguchi T; Kosho T; Fujiwara T; Harigae H; Ishida F
Rinsho Ketsueki; 2018; 59(4):401-406. PubMed ID: 29743399
[TBL] [Abstract][Full Text] [Related]
5. A Novel
Lee JS; Gu J; Yoo HJ; Koh Y; Kim HK
Ann Clin Lab Sci; 2017 May; 47(3):319-322. PubMed ID: 28667034
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation, Ile289Thr, in the ALAS2 gene in a family with pyridoxine responsive sideroblastic anaemia.
Percy MJ; Cuthbert RJ; May A; McMullin MF
J Clin Pathol; 2006 Sep; 59(9):1002. PubMed ID: 16935983
[No Abstract] [Full Text] [Related]
7. [Congenital sideroblastic anemia-a new family with identification of K156E mutation of ALAS2 gene and literature review].
Cui R; Xu Z; Qin T; Zhang Y; Xiao Z
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):142-6. PubMed ID: 24606657
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M; Malcovati L
Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
[TBL] [Abstract][Full Text] [Related]
9. Four new mutations in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causing X-linked sideroblastic anemia: increased pyridoxine responsiveness after removal of iron overload by phlebotomy and coinheritance of hereditary hemochromatosis.
Cotter PD; May A; Li L; Al-Sabah AI; Fitzsimons EJ; Cazzola M; Bishop DF
Blood; 1999 Mar; 93(5):1757-69. PubMed ID: 10029606
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding of inherited sideroblastic anaemia.
Camaschella C
Br J Haematol; 2008 Oct; 143(1):27-38. PubMed ID: 18637800
[TBL] [Abstract][Full Text] [Related]
11. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment.
Camaschella C
Semin Hematol; 2009 Oct; 46(4):371-7. PubMed ID: 19786205
[TBL] [Abstract][Full Text] [Related]
12. Disparate phenotypic expression of ALAS2 R452H (nt 1407 G --> A) in two brothers, one with severe sideroblastic anemia and iron overload, hepatic cirrhosis, and hepatocellular carcinoma.
Barton JC; Lee PL
Blood Cells Mol Dis; 2006; 36(3):342-6. PubMed ID: 16540354
[TBL] [Abstract][Full Text] [Related]
13. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
[TBL] [Abstract][Full Text] [Related]
14. A Novel g.55040074delT in ALAS2 Gene Resulting in a Monomeric Protein and Severe Sideroblastic Anemia Phenotype.
Bhatia P; Singh A; Hedge A
J Pediatr Hematol Oncol; 2017 Aug; 39(6):463-465. PubMed ID: 28731922
[TBL] [Abstract][Full Text] [Related]
15. [The Iron-man: a case-report].
Einarsdóttir MJ; Reykdal SE; Vidarsson B
Laeknabladid; 2011 Jan; 97(1):31-3. PubMed ID: 21217197
[TBL] [Abstract][Full Text] [Related]
16. Late-onset X-linked sideroblastic anemia following hemodialysis.
Furuyama K; Harigae H; Kinoshita C; Shimada T; Miyaoka K; Kanda C; Maruyama Y; Shibahara S; Sassa S
Blood; 2003 Jun; 101(11):4623-4. PubMed ID: 12531813
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia.
Cazzola M; Invernizzi R; Bergamaschi G; Levi S; Corsi B; Travaglino E; Rolandi V; Biasiotto G; Drysdale J; Arosio P
Blood; 2003 Mar; 101(5):1996-2000. PubMed ID: 12406866
[TBL] [Abstract][Full Text] [Related]
18. Multi-organ iron overload in an African-American man with ALAS2 R452S and SLC40A1 R561G.
Sussman NL; Lee PL; Dries AM; Schwartz MR; Barton JC
Acta Haematol; 2008; 120(3):168-73. PubMed ID: 19066423
[TBL] [Abstract][Full Text] [Related]
19. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
20. A double red cells population in a woman with a microcytic anemia.
Garçon L; Kannengiesser C
Blood; 2014 Feb; 123(6):808. PubMed ID: 24660232
[No Abstract] [Full Text] [Related]
[Next] [New Search]
